Table 2 Data Collection and participant retention at follow up.

From: A pilot randomised controlled trial of the Tailored Intervention for people with moderate-to-severe Chronic Obstructive Pulmonary Disease and Co-morbidities delivered by Pharmacists and Consultant respiratory Physicians (TICC-PCP)

Variable

Summary Statistic

N = 84

Average percentage of in-person data collected across all visits

(of those who did not die or develop incapacity by 21 month visit)

N (Nmissing)

Median (IQR)

84 (0)

89.5 (72.9, 92.3)

At least 80% of ITT participants (excluding those who died or developed incapacity before the end of the study) remaining in the study until 21 month data collection

 

Remained in study until 21 month visit

(of those who did not die or develop incapacity by 21 month visit)

N (Nmissing)

N (%) Yes

84 (0)

74 (88.0%)